179 related articles for article (PubMed ID: 20671117)
1. Association of Shp2 with phosphorylated IL-22R1 is required for interleukin-22-induced MAP kinase activation.
Meng S; Gui Q; Xu Q; Lu K; Jiao X; Fan J; Ge B; Ke Y; Zhang S; Wu J; Wang C
J Mol Cell Biol; 2010 Aug; 2(4):223-30. PubMed ID: 20671117
[TBL] [Abstract][Full Text] [Related]
2. SHP2 regulates IL-2 induced MAPK activation, but not Stat3 or Stat5 tyrosine phosphorylation, in cutaneous T cell lymphoma cells.
Lundin Brockdorff J; Woetmann A; Mustelin T; Kaltoft K; Zhang Q; Wasik MA; Röpke C; Ødum N
Cytokine; 2002 Nov; 20(4):141-7. PubMed ID: 12543077
[TBL] [Abstract][Full Text] [Related]
3. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
4. Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway.
Koyama T; Nakaoka Y; Fujio Y; Hirota H; Nishida K; Sugiyama S; Okamoto K; Yamauchi-Takihara K; Yoshimura M; Mochizuki S; Hori M; Hirano T; Mochizuki N
J Biol Chem; 2008 Aug; 283(35):24234-44. PubMed ID: 18577518
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
[TBL] [Abstract][Full Text] [Related]
6. The multi-site docking protein Grb2-associated binder 1 (Gab1) enhances interleukin-6-induced MAPK-pathway activation in an SHP2-, Grb2-, and time-dependent manner.
Bongartz H; Gille K; Hessenkemper W; Mandel K; Lewitzky M; Feller SM; Schaper F
Cell Commun Signal; 2019 Oct; 17(1):135. PubMed ID: 31651330
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth.
Zorina Y; Iyengar R; Bromberg KD
J Biol Chem; 2010 Jan; 285(2):1358-70. PubMed ID: 19861414
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.
Lee IO; Kim JH; Choi YJ; Pillinger MH; Kim SY; Blaser MJ; Lee YC
J Biol Chem; 2010 May; 285(21):16042-50. PubMed ID: 20348091
[TBL] [Abstract][Full Text] [Related]
10. The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.
Dance M; Montagner A; Salles JP; Yart A; Raynal P
Cell Signal; 2008 Mar; 20(3):453-9. PubMed ID: 17993263
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.
Cunnick JM; Meng S; Ren Y; Desponts C; Wang HG; Djeu JY; Wu J
J Biol Chem; 2002 Mar; 277(11):9498-504. PubMed ID: 11779868
[TBL] [Abstract][Full Text] [Related]
12. SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.
Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
Int J Oncol; 2014 Feb; 44(2):481-90. PubMed ID: 24297342
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
14. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
Fragale A; Tartaglia M; Wu J; Gelb BD
Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.
Nagalakshmi ML; Rascle A; Zurawski S; Menon S; de Waal Malefyt R
Int Immunopharmacol; 2004 May; 4(5):679-91. PubMed ID: 15120652
[TBL] [Abstract][Full Text] [Related]
16. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
17. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
He HY; Zheng J; Li Y; Heng WJ; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2.
Chen C; Cao M; Zhu S; Wang C; Liang F; Yan L; Luo D
Sci Rep; 2015 Dec; 5():17626. PubMed ID: 26626996
[TBL] [Abstract][Full Text] [Related]
19. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity.
Bode JG; Gatsios P; Ludwig S; Rapp UR; Häussinger D; Heinrich PC; Graeve L
J Biol Chem; 1999 Oct; 274(42):30222-7. PubMed ID: 10514514
[TBL] [Abstract][Full Text] [Related]
20. M-CSF elevates c-Fos and phospho-C/EBPalpha(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification.
Jack GD; Zhang L; Friedman AD
Blood; 2009 Sep; 114(10):2172-80. PubMed ID: 19587381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
